Acurx Pharmaceuticals Inc (ACXP)
2.27
+0.11
(+5.09%)
USD |
NASDAQ |
May 17, 16:00
2.27
0.00 (0.00%)
After-Hours: 20:00
Acurx Pharmaceuticals Free Cash Flow: -10.93M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -10.93M |
| December 31, 2023 | -9.801M |
| September 30, 2023 | -7.099M |
| June 30, 2023 | -7.185M |
| March 31, 2023 | -7.599M |
| December 31, 2022 | -7.542M |
| September 30, 2022 | -7.547M |
| Date | Value |
|---|---|
| June 30, 2022 | -8.003M |
| March 31, 2022 | -6.343M |
| December 31, 2021 | -5.014M |
| September 30, 2021 | -4.473M |
| June 30, 2021 | -2.596M |
| March 31, 2021 | -2.999M |
| December 31, 2020 | -3.352M |
Free Cash Flow Range, Past 5 Years
-10.93M
Minimum
Mar 2024
-2.596M
Maximum
Jun 2021
-6.463M
Average
-7.142M
Median
Free Cash Flow Benchmarks
| Seelos Therapeutics Inc | -18.21M |
| Tonix Pharmaceuticals Holding Corp | -90.87M |
| PetVivo Holdings Inc | -7.600M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.063M |
| Cash from Financing (Quarterly) | 4.510M |
| Free Cash Flow Per Share (Quarterly) | -0.198 |
| Free Cash Flow Yield | -35.65% |